Description

1. Overview

GHK-Cu (Copper Tripeptide-1) is a copper-binding peptide composed of glycine, histidine, and lysine complexed with copper. It has been studied for its potential roles in skin remodeling, collagen-related processes, wound repair, inflammation, and tissue regeneration. Most evidence remains preclinical, while human evidence is limited and is primarily associated with topical cosmetic applications.

2. Potential Benefits Under Research

• Skin appearance: Investigated for effects on skin texture and signs of aging.
• Collagen and elastin: Laboratory studies suggest effects on pathways involved in extracellular-matrix remodeling.
• Wound healing: Being studied for its potential role in tissue repair.
• Skin regeneration: Research has examined cellular processes involved in dermal repair.
• Anti-inflammatory activity: Preclinical research has investigated effects on inflammatory and oxidative-stress pathways.
• Hair-related applications: Small human cosmetic studies have explored topical GHK-Cu in hair/eyebrow applications.

These should be regarded as research findings rather than guaranteed therapeutic benefits.

3. How It Works

GHK-Cu interacts with copper and biological signaling pathways involved in extracellular-matrix remodeling, tissue repair, inflammation, and cellular signaling. Its precise clinical mechanism and the importance of different GHK-Cu formulations remain under investigation.

4. GHK-Cu 100 mg

100 mg indicates the stated amount of GHK-Cu in a particular product. It should not be interpreted as an established therapeutic dose. There is no FDA-approved 100 mg GHK-Cu treatment regimen, and injectable/systemic use has not been adequately established in controlled human studies.

5. Possible Side Effects & Safety

For topical cosmetic use, available evidence suggests generally favorable tolerability, although data are limited. The safety picture is substantially less established for injectable GHK-Cu, where systematic human safety data are lacking and regulatory safety concerns have been raised.

6. Regulatory Status

GHK-Cu is not FDA-approved for any medical indication. A clinical study of topical GHK-Cu for standardized wounds is currently being investigated, but registration of a study does not establish effectiveness.

7. Conclusion

GHK-Cu 100 mg is best described as an investigational copper peptide. Research is particularly focused on skin biology, tissue repair, and regenerative processes, but evidence is not sufficient to establish injectable GHK-Cu as a proven medical treatment.